Updated Jan. 26, 2011 at 6:25 a.m.

Premium Lock GSK's top U.S. exec: Company is changing business approach

Published: 2011-01-25 15:03:00
Updated: 2011-01-26 06:25:21

Print this blog post
Deirde Connelly Deirde Connelly (GSK photo)

Deirdre Connelly, who is based in RTP, says that the drug giant is implementing changes across the company in the wake of law suits, investigations and legal claims. GSK has been fined heavily for drug production problems and also has set aside billions of dollars to settle legal cases against its diabetes drug Avandia....Copyright 2013 WRAL Tech Wire. All rights reserved.

Please log in or register to view WRALTechWire Insider content


To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.

 1 Year Membership - 49.99 per year. Includes FREE unlimited access to online content, archives and discounts from Insider Partners. For less than $1 a week receive more than $900 in value.

 Monthly Membership - 4.99 per month. Includes FREE unlimited access every 30 days to online content only.

 Day Pass - 0.99 per day. Includes FREE unlimited access for 24 hours to online content only.

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Jim Roberts
Entrepreneurship
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll